Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma, Malignant × Erlotinib Hydrochloride × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 122 Lung Neoplasms 46 Pancreatic Neoplasms 29 Non-Squamous Non-Small Cell Lung Cancer 15 Neoplasms 15 Glioblastoma 12 Gliosarcoma 11 Breast Neoplasms 11 Adenocarcinoma of Lung 11 Brain Neoplasms 10 Neoplasm Metastasis 9 Head and Neck Neoplasms 9 Carcinoma, Renal Cell 7 Carcinoma, Hepatocellular 7 Carcinoma, Squamous Cell 6 Astrocytoma 6 Adenocarcinoma, Bronchiolo-Alveolar 6 Squamous Cell Carcinoma of Head and Neck 5 Oligodendroglioma 5 Urinary Bladder Neoplasms 4 Glioma 4 Esophageal Neoplasms 4 Colorectal Neoplasms 4 Carcinoma 4 Adenocarcinoma 4 Recurrence 3 Rectal Neoplasms 3 Ovarian Neoplasms 3 Liver Neoplasms 3 Kidney Neoplasms 3

Interventions

Pemetrexed 14 Cisplatin 13 pembrolizumab 4 Platinum 4 1,2-diaminocyclohexaneplatinum II citrate 4 Radiotherapy 3 Gemcitabine 3 Carboplatin 3 cediranib 2 amatuximab 2 Radiotherapy, Intensity-Modulated 2 Radiation 2 Drug Therapy 2 Cyclophosphamide 2 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tremelimumab 1 sodium thiosulfate 1 sargramostim 1 nintedanib 1 napabucasin 1 methoxyamine 1 liposomal doxorubicin 1 incomplete Freund's adjuvant 1 fresolimumab 1 durvalumab 1 defactinib 1 cixutumumab 1 bintrafusp alfa protein, human 1 bemcentinib 1 belinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡